Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH

J Exp Med. 1994 Aug 1;180(2):751-5. doi: 10.1084/jem.180.2.751.

Abstract

The predominant peptides bound to major histocompatibility complex class II molecules expressed on human B cells are derived from a relatively limited number of self proteins. To determine whether any of the prebound self peptides might be released in endosomes during recycling, water-soluble HLA-DR1 molecules were incubated with a high affinity synthetic peptide at pH 4.0 and 7.0 at 37 degrees C. The resulting bound peptide repertoire was then acid extracted, and separated by reversed-phase high performance liquid chromatography. Using a combination of mass spectrometry and ultraviolet spectroscopy, prebound self peptides and newly bound synthetic peptide were characterized. Most self peptides bound to HLA-DR1 were not appreciably released during extended exposure to pH 4.0. However, some invariant chain-derived peptides were uniquely released at this pH.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Differentiation, B-Lymphocyte*
  • B-Lymphocytes / metabolism*
  • Cattle
  • HLA-DR1 Antigen / metabolism*
  • Histocompatibility Antigens Class II / metabolism*
  • Humans
  • Hydrogen-Ion Concentration
  • Molecular Sequence Data
  • Organelles / metabolism

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • HLA-DR1 Antigen
  • Histocompatibility Antigens Class II
  • invariant chain